




Two stem cell states have been identified within the crypts of the small intestine: 
‘quiescent’ and ‘active’. SOX9, a transcription factor encoded from the Sox9 gene has been 
hypothesized to be the master regulator between these ‘active’ (low expression of SOX9) and 
‘reserve’ (high expression of SOX9) intestinal stem cell states. Therefore, putative cis-regulatory 
sequences upstream of the SOX9 promoter have been analyzed through TRANSFAC© to 
determine potential candidates for up-regulation of SOX9 in quiescent and active stem cells. 
Preliminary results indicate that FOXA1and A2 represent potential transcriptional regulators of 
the SOX9 gene. This hypothesis has been supported by immunohistochemistry, qRT-PCR 
analysis, and ChIP-sequencing demonstrating that FOXA1/2 co-expresses in cells that express 
high levels of SOX9 within the intestinal crypt. These studies provide further understanding of 
how stem cell identity is normally regulated in the cells of the intestinal crypt.  
Introduction:  
The mammalian intestinal tract contains a single monolayer of epithelial cells that 
regenerates every six to seven days
1
. This extremely high cell turnover rate makes the intestine a 
great model for the study of cell proliferation and 
differentiation.  In order to maintain such high 
renewal levels, a small population of actively 
dividing stem cells resides within the intestinal 




 Within these intestinal crypts, two stem cell 
states have been identified: ‘active’ and ‘reserve’ 
 
 
Figure 1: Diagram showing the base of 
the crypt. Active and reserve cells are 
labeled on the diagram. 
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(Figure 1). The ‘active’ stem cells inhabit the base of the crypt between the 0-4 positions while 
the ‘reserve’ stem cells are located just above the active stem cells in the +4 position, which is 
defined as 4-cell positions from the crypt bottom (Figure 1)
2
. Normally, these ‘active’ cells are 
constantly dividing and supplying new cells to replace the cells in the intestinal epithelium. In 
contrast, the ‘reserve’ stem cells seem to remain relatively quiescent with a low cellular division 
rate. These cells can be “activated” upon loss of the active cells due to injury or disease and 
begin to start dividing to compensate for the lost stem cells
3
. Interestingly, each population has 
been found to express distinct levels of the SOX9 transcription factor (Figure 2). The ‘active’ 
stem cells have been found to express ‘low’ levels of Sox9 protein while the ‘reserve’ stem cells 
express ‘high’ levels of Sox9 protein
3-5
. SOX9 belongs to the larger transcription family of 
“SOX” factors, a large family of transcription factors that are expressed in nearly all stem and 
progenitor cell populations
3-5
. In addition, deviations in the normal expression pattern of Sox-
factors have been linked to numerous physical anomalies when incorrectly expressed or 
genetically insufficient. For example, hypomorphic levels of SOX2 have been linked to 
conditions of anopthalmia (absence of one eye in development) and micropthalmia (development 
of one or two small eyes) which is due to the loss of ‘stemness’ and the ability to proliferate
6
. 
Collectively, SOX factors have been linked in playing a crucial role in the proliferation and 
differentiation of stem cells in various body tissues.  
 As previously mentioned, the active stem cells have been found to express relatively low 
levels of SOX9 while the quiescent stem cells express high levels of SOX9 (Figure 2).  Studies 
demonstrate that SOX9 levels are inversely correlated with proliferative capacity
7
. In other 
words, low levels of SOX9 are associated with rapidly dividing cells and high SOX9 levels are 
associated with slowly dividing or non-dividing cells
3,4
. Additionally, when SOX9 is 
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overexpressed in an actively 




Therefore, we hypothesize that 
SOX9 levels are the master 
regulator between the active and 
reserve stem cell state and that 
up-regulation of Sox9 in the 
reserve population is regulated 
by cell-specific cis-elements. To test this hypothesis, the following aims were conducted: 
Aim 1: Analyze the upstream promoter region of the SOX9 gene and identify candidate cis-
regulatory sequences that could potentially be involved in up-regulation of SOX9 in the reserve 
stem cell population.  





cells by using quantitative real-time polymerase chain reaction (qPCR) and 
immunohistochemical analysis. .  
Aim 3: To test these candidate transcription factors for their ability to up-regulate and down-
regulate SOX9 in cultured primary cells using qPCR.  
Methods and Results:  
First, the upstream sequence of SOX9 in Mus Musculus was extracted from the NIH genome 
database beginning at position 112,923,528bp upstream to position 112,535,205bp. This 
sequence was then uploaded to Vector NTi© software which was subsequently cut to the 
appropriate length of 150,000 base pairs: 112,923,528-112,773,528bp (this section begins in the 
 
Figure 2: Sox9EGFP (and endogenous SOX9 – red) is 
expressed at ‘low’ levels in the active stems and ‘high’ 
















second coding exon of SOX9 and continues 150 kilo-base pairs upstream of this position). This 
region was chosen as most promoter regions have been found to be within the first 100kb 
upstream of the gene of interest
8
.  
 From here, the sequence was broken into 15 10,000bp fragments and transferred to 
TRANSFAC, a program that can detect candidate transcription factors that could bind to a 
particular DNA sequence based on the organism specified.  Each of these segments was filtered 
through the program under settings to minimize false positive and under all vertebrate TFs to 
determine candidate proteins that could bind along the sequence. As well as this, at each junction 
where a new segment began, an extra sequence taken 500bp from either side of the junction was 
also analyzed to ensure no transcription factors were missed in the analysis of the upstream 
sequence. Each sequence produced approximately 350 candidate Transcription factors (Figure 3) 










Table 1: Output matrix received by 
MATLAB Candidate 1 had the highest 
frequency of appearance with the 
associated highest core binding scores.  
 
 Using MATLAB, a function was created taking the TRANSFAC input files of 
transcription factors, their appropriate binding sequence and their core binding score. This 
function took the five most prevalent/frequently appearing Transcription factors that also had the 
highest binding score and returned them as a small output matrix displayed below:  
 
 Although significant, the results were not 
conclusive enough to determine if these transcription 
factors were actually worth in vivo and in vitro 
analysis. Next, another genome browser source was 
recruited: the UCSC genome data browser. This 
resource allowed the manipulation of human and 
mouse stem cell lines to see potential expression of 
either promoting or regulatory sequences for 
specified genes.   
 
 
Figure 4: UCSC genome browser: Analysis of SOX9 gene (black box) and the upstream 
promoter sequence (using human stem cell lines). Both FOXA1 and FOXA2 are found about 
40,000bp upstream (red arrow) of SOX9 gene sequence in the promoter region. ChIP sequencing 











Table 2: Table of highest 
cluster scoring transcription 
factors. All data was obtained 
using UCSC genome browser. 
 
 





Table 3: Candidate transcription 
factors that appear both in 
TRANSFAC and UCSC analysis. 
The second column includes 
candidates that appear in either 
one or the other program.  
 
particular region suggesting that both FOXA1 and FOXA2 could regulate the transcription of the 
SOX9 gene in intestinal crypt stem cells (red box). 
 
 Each of these regions was analyzed by the UCSC browser using TF-ChIP sequencing. 
This ChIP sequencing process is used to analyze protein interaction with DNA and each protein 
analyzed is given a corresponding “cluster score” based on the 
sequencing program. The cluster score returns a value from 0 
to 1000 where a score of 1000 indicates a high binding 
affinity of a transcription factor for a particular DNA binding 
sequence
10
. Using these parameters, the highest cluster 
scoring transcription factors were found as the following (see 
left): 
 These two examined regions occur roughly 40,000bp 
upstream of SOX9 and 70,000bp downstream of Sox9. Each of these regions produced similar 
results (Table 2). However, the upstream region was deemed more significant than the 
downstream expression region as there are very few 
examples in vertebrates detailing downstream promoting 
regions (note- some examples have been found in 
Drosophila)
 11
. Taking the data from the two programs: 
TRANSFAC and UCSC, three transcription factors 
provide the best evidence for regulation of the SOX9 
gene, based on appearing in both research sets: (Table 3)  
 A literature review was then conducted on the 
above transcription factors to determine if in fact these 
proteins have been documented in the intestine and have an observed function (a summary of the 
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papers reviewed for FoxA1/A2 is detailed in Supplementary Table 1). In summary, the 
candidates producing the highest likelihood for activity and function in the intestinal tract 
centered on FOXA1 and FOXA2. In Sluis et. al, the authors noted that goblet cells in the 
intestine, normally responsible for secretion of mucus around the villi (fingerlike projections in 
the intestine normally providing protection against stomach acids) were reduced in number upon 
the deletion of FOXA1 and FOXA2
12
. Muc2, the protein responsible for secretion of this mucus, 
was found to be regulated by FOXA1 and FOXA2. In this case, knocking out either FOXA1 or 
FOXA2 resulted in a marked decrease in Muc2 expression and a double mutant resulted in 
significantly larger decrease in Muc2 expression. Additionally, a paper by Ye and Keastner 
detail that both of these FOX factors were once again involved in goblet cell Muc2 expression 
and propaglucagon expression in enteroendocrine cells
13
. These enteroendocrine cells normally 
provide hormonal growth regulation in the small intestine. The authors noted in their figures that 
SOX9 expression was found in all epithelial cells in the intestine and also hypothesized a link to 
stem cell differentiation. Finally, a paper by Landeghem et. al.
3
 provided further analysis of these 
FOX factors. In the paper’s supplemental table 3, the authors irradiated Sox9GFP mice and 
analyzed cell populations including SOX9-HI or “quiescent” stem cells and subsequently 
checked gene expression following irradiation. FOXA1 was found to be in these quiescent stem 
cells and demonstrated a 10.7 fold decrease in expression upon irradiation. FOXA2 also 
demonstrated a decrease in expression albeit smaller, at 6.7 fold. In the irradiated SOX9-LO or 
“active” stem cells, FOXA1 and A2 were not found to be expressed in these cells. Interestingly, 
FOXA1 and FOXA2 were always found co-expressed. This could indicate that FOXA1 and A2 
expression could be linked to SOX9 expression in the quiescent stem cells.  
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With some initial evidence indicating that FoxA1 and A2 expression could be linked to Sox9 
expression, the next step taken was to analyze expression levels of FoxA1 and A2 in different 
intestinal crypt cell populations by qRT-PCR(quantitative real time polymerase chain reaction). 
This technique employs an oligonucleotide probe which hybridizes to the target DNA sequence 
and amplifies the signal which can then be quantified and validated through StepOne software.  
The experiment was run against a control Sox9 negative population of intestinal cells (taken 
from the intestinal epithelium). In this way, each intestinal crypt population’s gene expression 
levels can be analyzed relative to the baseline expression level for each gene  in the Sox9 





Figure 5: FOXA1 and FOXA2 levels are up-regulated in SOX9HI cell populations (N=3)** 
*Above each cell population indicate that they are statistically different from each other: p<0.05 
performed by T.Test.  
**All Data was obtained from quantitative real-time PCR analysis on the above Intestinal crypt 
cell populations. (N.D displayed over the Paneth cell populations indicates no gene expression 
was observed) 
 
In regards to each cell population above, the HI population represents cells that are 
indicative of quiescent stem cell populations in the crypt, the LO population represents cells that 
are representative of active stem cells in the crypt.  Sub-LO stem cells represent progenitor cells 
in the intestinal crypt which are multipotent cells that will divide into other enteroendocrine, 
goblet, and tuft cells in the epithelium. Finally, Paneth cells represent cells present at the bottom 
of the crypt which provide growth factors for the active stem cells. qPCR for genes known to be 
associated with each population was conducted to validate FACS sorting for the above 
populations (Supplemental Table 2). FoxA1 and FoxA2 expression correlates with Sox9 
expression in the HI populations, indicating that the expression level FoxA1/A2 could be linked 
to the high expression of Sox9 in the quiescent stem cell populations (Figure 6).  
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Next, FoxA1 and FoxA2 expression was analyzed by immunohistochemistry in the 
intestinal crypts (Figure 6). Immunohistochemical analysis employs antibodies which are raised 
in a particular host animal and specifically bind to the protein of interest. For this first antibody 
stain, slides containing mouse intestinal tissue were stained with Sox9
GFP 
and FoxA2 antibody to 
test if Sox9 and FoxA2 co-localize in the same cells in the intestinal crypt. Sox9
GFP 
antibody 
replaces the Sox9 gene with GFP which provides a more robust expression pattern and it thus 
more easily identifiable in the intestine. DAPI is also used as a well-characterized nuclear marker 
as it binds specifically to each cell’s nucleus to aid in seeing if the protein of interest co-localizes 





 The next staining for FoxA1 and A2 is co-stained with chromagranin A, a protein which 
is normally expressed in the cytoplasm of quiescent stem cell populations
5
. The results of the 





 Although the initial staining of Sox9
GFP
 and FoxA2 co-localizes in the same cell, it was 
necessary to test endogenous sox9 expression and see if FoxA2 expression co-localized in the 
same cellular region. In this case, Sox9 is expressed nuclearly in the intestinal crypt with a cell 
expressing high levels of being highlighted with the white arrow (Figure 8-ii). This high nuclear 
expression of Sox9 is indicative of a quiescent stem cell in the crypt and high levels of FoxA2 
seem to co-localize nuclearly in the same cell. (Figure 8-iii/iv). Once again, although this is 
indicative of FoxA2 expression levels affecting Sox9 expression, this simply proves that FoxA2 
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and Sox9 are co-localizes within the same regions within the quiescent stem cell providing 
evidence to the above hypothesis that FoxA2 could be regulating Sox9 expression.  
 
Other stains were performed against MUC2 and LYZ to assay if FoxA2 expression co-
localizes in goblet or paneth cells, respectively. Goblet cells are also found in the intestinal crypt 
and are responsible for secreting mucins to line the intestinal epithelium. Paneth cells are 
responsible for secreting growth factors that assist the actively dividing stem cells at the base of 
the crypt. Results show that LYZ and MUC2 do not co-localize in cells that express FOXA2 








Based on qRT-PCR and immunohistochemistry analysis, the main conclusion that can be 
reached on the research performed is that Foxa1 and Foxa2 expression levels correlate with 
intestinal crypt cells expressing high levels of Sox9. The endogenous Sox9/FoxA2 co-stain 
furthers this conclusion as FoxA2 not only co-localizes in cells expressing high levels of Sox9, 
but also co-localizes nuclearly where high expression of endogenous Sox9 is observed.  The next 
step in the project is the development of a lentiviral vector to overexpress FoxA1/2 in cell 
populations (for example Sox9LO stem cells in the intestinal crypt) that normally express low 
levels of Sox9 and see if Sox9 expression is up-regulated ( An example of the constructed 




This would suggest that up-regulation of FoxA1/2 could in turn cause the up-regulation 
of Sox9. Another future experiment will involve ChIP analysis on intestinal stem cell 
populations to confirm that FoxA1/A2 could be binding to the Sox9 DNA sequence in these 
intestinal cells which would indicate that the transcription factor could be regulating Sox9 gene 
expression. Finally one other experiment that could be used to further the hypothesis that 
FoxA1/A2 are involved in the regulation of Sox9 would be the development of a conditional 
knockout mouse for FoxA1/A2 in the intestine. Using this knockout mouse, tissue samples could 
be obtained for immunohistochemical analysis.  Staining the tissue should result in a decreased 
expression of Sox9 in quiescent stem cells. As well as this, Kasetner’s paper indicates that 
reduced levels of FoxA1 and A2 reduce the amount of goblet cells and enteroendocrine cells 
which could be validated by chgA and Muc2 staining the tissue. A decrease in the above cell 
types should thus be observed
13
.  
Consequently, if FOXA1/A2 is then found to be involved in the suppression of the active 
state of stem cells, this could eventually become a target for gene therapy. Since the quiescent 
stem cell becomes activated under intestinal damage/irradiation (upon de-regulation of SOX9), 
by targeting the FOXA1/A2 gene for suppression, this could induce the cell to become active and 
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These three papers below provided the best evidence for continuing experimentation of 
FoxA1/A2 in the intestinal crypt and a small summary of each paper is detailed below:  
1. Van der Sluis et al. “Forkhead box transcription factors Foxa1 and Foxa2 are important 




The authors demonstrated in this paper that both FoxA1 and FoxA2 could each bind to the 
Muc2 promoter and cause upregulation in intestinal epithelial cells. Although both 
transcription factors were capable of binding the promoter, FoxA1 was found to be slightly 
more efficient with increased expression of Muc2 relative to FoxA2. The important 
conclusion from this paper is that FoxA1 and A2 are found in the intestine and are involved 
in the expression of other intestinal genes.  
2. Ye, Diana. Kaestner, Klaus. “Foxa1 and Foxa2 Control the Differentiation of Goblet and 
Enteroendocrine L- and D-Cells in Mice”. Gastroenterology. Pub Dec. 2009. 
Continuin from the above, the major development in Kaestner’s paper was the development 
of a conditional knockout mouse for FoxA1/A2 which was found to decrease the amount of 
goblet and enteroendocrine cells in the intestinal epithelium providing further evidence for 
FoxA1/A2 playing an important role in the intestine.  
3. Serfas et. al.  “HNF-1 alpha and HNF-1 beta expression in mouse intestinal crypts”. 
Journal of American Physiology. Pub. Sept 1993.  
Although the previous papers had demonstrated FoxA1/A2 in the epithelium, there was still no 
evidence of FoxA1/A2 expression in the intestinal crypts. Serfas concluded that first FoxA1.A2 
expression was higher in the intestine relative to liver, and kidney. Specifically in the intestine, 
Murphy 19 
 
FoxA1.A2 levels were also found to be up-regulated in the crypts relative to the villus indicating 
that some cell types in the villus had high expression levels of FoxA1/A2.  
qRT-PCR was also ran on Muc2, ChgA, and Lyz2 to validate that the cell populations used in  
the experiment were indicative of each cell type found in the crypt. Muc2 expression should be 
highest in the Negative and Sub-Lo populations as these represent epithelial cells which have 
many goblet cells (high expression of Muc2) as well as progenitor cells that are dividing into 
goblet cells. Chromagranin A is commonly found in enteroendocrine cells, which express 
various hormones to maintain homeostasis in the intestinal crypt and epithelium. It has also been 
characterized as a marker for quiescent stem cells. Finally, Lyz2 is a characterized marker for 
Paneth cells which normally provide growth factors for the actively dividing stem cells in the 






Figure 10: qRT-PCR analysis for Muc2, ChgA and Lyz2 expression levels in the above cell 
populations. These results were used to validate the cell population used in the experiment.  
 
These tests were therefore performed to help validate that the cell populations have the 
appropriate expression levels for each gene.  
Immunohistochemistry supplemental pictures: 
As mentioned in the methods and results section of the paper, two additional co-stains 
were performed in the experiment, a Muc2/FoxA2 costain and a Lyz2/FoxA2 co-stain. These 
were performed as a control to ensure that high FoxA2 expressing cells were not co-localizing 
with cells that express high levels of Muc2 or Lyz2. If the FoxA2 high-expressing cells were 
found to have high levels of Muc2, then FoxA2 would be co-localizing with goblet cells which 
would weaken the initial hypothesis of high levels of FoxA2 co-relating with high levels of Sox9 
expression. In the same vein, if cells expressing high levels of FoxA2 were co-localizing in cells 
expressing high levels of Lyz2, then it would be co-expressing in paneth cells which would also 




From the above figure, the high FoxA2 expressing cell in the intestinal crypt (indicated 
by the white arrow does not co-localize in the cells in the base of the crypt expressing high levels 
of lysozyme protein.  
 In the Muc2/FoxA2 co-stain below, the FoxA2 high expressing cells are indicated by the 
white arrows. Once again, the cells expressing high levels of FoxA2 do not co-localize in cells 
expressing high levels of Muc2 protein.  
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